Regeneron Pharmaceuticals (REGN) Selling, General & Administrative (2009 - 2026)
Regeneron Pharmaceuticals' Selling, General & Administrative came in at $662.1 million for Q2 2026, up 4.4% from $634.2 million a year earlier and up 2.2% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regeneron Pharmaceuticals reported Selling, General & Administrative of $2.74 billion, down 1.1% year-over-year; for FY2025, it was $2.7 billion, down 8.6% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of 14.9% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $2.95 billion in FY2024 (+12.3%), $2.63 billion in FY2023 (+24.4%), $2.12 billion in FY2022 (+15.9%) and $1.82 billion in FY2021 (+35.6%).
- The five-year range for quarterly Selling, General & Administrative is $445 million (Q3 2021) to $792.2 million (Q4 2024).
- Year-over-year, Selling, General & Administrative increased in four of the last eight quarters, with an average decline of 1.1%.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q4 2021 (growth of 84.4%), and the weakest in Q2 2025 (a decline of 16.4%).
- Business Quant data shows REGN's Selling, General & Administrative at $647.7 million (Q1 2026), $775 million (Q4 2025) and $657.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 662.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 662.10 Mn |
| Mar 31, 2026 | 647.70 Mn |
| Dec 31, 2025 | 775.00 Mn |
| Sep 30, 2025 | 657.80 Mn |
| Jun 30, 2025 | 634.20 Mn |
| Mar 31, 2025 | 633.00 Mn |
| Dec 31, 2024 | 792.20 Mn |
| Sep 30, 2024 | 714.40 Mn |
| Jun 30, 2024 | 758.80 Mn |
| Mar 31, 2024 | 689.00 Mn |
| Dec 31, 2023 | 737.70 Mn |
| Sep 30, 2023 | 640.50 Mn |
| Jun 30, 2023 | 652.00 Mn |
| Mar 31, 2023 | 601.10 Mn |
| Dec 31, 2022 | 660.50 Mn |
| Sep 30, 2022 | 529.10 Mn |
| Jun 30, 2022 | 476.30 Mn |
| Mar 31, 2022 | 450.00 Mn |
| Dec 31, 2021 | 559.60 Mn |
| Sep 30, 2021 | 445.00 Mn |
API Access
Regeneron Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();